Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse

被引：54

作者：

Voruganti, LNP ^{[1
]}

Heslegrave, RJ ^{[1
]}

Awad, AG ^{[1
]}

机构：

[1] UNIV TORONTO,DEPT PSYCHIAT,CLIN PSYCHOPHARMACOL PROGRAM,TORONTO,ON,CANADA

来源：

JOURNAL OF NERVOUS AND MENTAL DISEASE | 1997年 / 185卷 / 07期

关键词：

D O I：

10.1097/00005053-199707000-00008

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：463 / 465

页数：3

共 10 条

[1]

ALBANESE MJ, 1994, AM J PSYCHIAT, V151, P780

[2] Patients subjective experiences on antipsychotic medications: Implications for outcome and quality of life [J].

Awad, AG ;

Hogan, TP ;

Voruganti, LNP ;

Heslegrave, RJ .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 :123-132

[3] SUBJECTIVE RESPONSE TO NEUROLEPTICS IN SCHIZOPHRENIA [J].

AWAD, AG .

SCHIZOPHRENIA BULLETIN, 1993, 19 (03) :609-618

[4]

DIXON L, 1991, AM J PSYCHIAT, V148, P224

[5] NEUROLEPTIC DYSPHORIA [J].

EMERICH, DF ;

SANBERG, PR .

BIOLOGICAL PSYCHIATRY, 1991, 29 (03) :201-203

[6]

KHANTZIAN EJ, 1985, AM J PSYCHIAT, V142, P1259

[7]

REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511

[8]

VANPUTTEN T, 1984, AM J PSYCHIAT, V141, P16

[9] RATING OF MEDICATION INFLUENCES (ROMI) SCALE IN SCHIZOPHRENIA [J].

WEIDEN, P ;

RAPKIN, B ;

MOTT, T ;

ZYGMUNT, A ;

GOLDMAN, D ;

HORVITZLENNON, M ;

FRANCES, A .

SCHIZOPHRENIA BULLETIN, 1994, 20 (02) :297-310

[10]

WEIDEN P, 1989, COMPR PSYCHIAT, V30, P543

← 1 →